Search

Current filters: Hepatitis C, Infections and cancers, Treatment

The Hep C Revolution

From The Positive Side - Fall 2016
2016, CATIE
Client resources - Webpage

Caution needed about claims of increased risk of liver cancer recurrence with use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Looking back at liver cancer rates among people who received interferon therapy

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Barcelona: Reports of unexpected cases of liver cancer in people undergoing treatment with DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Vienna doctors urge caution when assessing possible associations between liver cancer recurrence and use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Bologna researchers find no link between DAAs and liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Large review from three French studies finds no link between use of DAAs and recurrence of liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir in HIV co-infection

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

2016, CIHR Canadian HIV Trials Network (CTN)
Guideline or manual - Webpage
More info

Alcohol, not marijuana, linked to liver injury in women with both HIV and hepatitis C

2016, CATIE
Research summary - Webpage